Fundraising Fox
Forward Tx
Founded 2022 · 12 employees on LinkedIn · 2 known investors
Find your way into Forward Tx
Sign up to see every warm intro you have to Forward Tx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Forward Tx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Forward Therapeutics develops oral small-molecule medicines targeting inflammation-driven diseases, using a structure-based, data-driven discovery engine to design drugs against validated pathways. The company applies expertise in chemistry, immunology, CNS biology, and clinical development.
Investors · 2
OrbiMed✓ confirmed by Forward TxNew York · $1M – $75M
How we know: OrbiMed's portfolio page · the company's own site · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Forward Tx do?
- Forward Therapeutics develops oral small-molecule medicines targeting inflammation-driven diseases, using a structure-based, data-driven discovery engine to design drugs against validated pathways. The company applies expertise in chemistry, immunology, CNS biology, and clinical development.
- Who are Forward Tx's investors?
- Forward Tx's investors include OrbiMed, Curie.Bio.